Concepts (275)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Retinal Ganglion Cells | 15 | 2024 | 106 | 5.130 |
Why?
|
| Intraocular Pressure | 17 | 2023 | 125 | 4.770 |
Why?
|
| Glaucoma | 9 | 2022 | 72 | 3.670 |
Why?
|
| Ocular Hypertension | 5 | 2023 | 24 | 2.190 |
Why?
|
| Retinal Degeneration | 4 | 2024 | 101 | 1.500 |
Why?
|
| Color Vision | 3 | 2020 | 11 | 1.340 |
Why?
|
| Retina | 9 | 2024 | 486 | 1.020 |
Why?
|
| Optic Nerve Diseases | 2 | 2018 | 52 | 0.970 |
Why?
|
| Nerve Degeneration | 2 | 2018 | 127 | 0.940 |
Why?
|
| Intracranial Hypertension | 2 | 2018 | 111 | 0.930 |
Why?
|
| Disease Models, Animal | 10 | 2020 | 4435 | 0.890 |
Why?
|
| Ophthalmologists | 1 | 2023 | 10 | 0.840 |
Why?
|
| Contrast Sensitivity | 3 | 2020 | 42 | 0.810 |
Why?
|
| Virtual Reality | 1 | 2023 | 31 | 0.810 |
Why?
|
| Glaucoma, Open-Angle | 4 | 2021 | 36 | 0.810 |
Why?
|
| Color Perception | 1 | 2022 | 12 | 0.740 |
Why?
|
| Dark Adaptation | 3 | 2016 | 35 | 0.710 |
Why?
|
| Amacrine Cells | 2 | 2020 | 42 | 0.690 |
Why?
|
| Adaptation, Ocular | 1 | 2020 | 18 | 0.670 |
Why?
|
| Primary Cell Culture | 1 | 2020 | 103 | 0.670 |
Why?
|
| Light | 2 | 2020 | 167 | 0.660 |
Why?
|
| Capillaries | 1 | 2020 | 70 | 0.660 |
Why?
|
| Retinal Vessels | 1 | 2020 | 74 | 0.640 |
Why?
|
| Regional Blood Flow | 1 | 2020 | 197 | 0.640 |
Why?
|
| Neuroprotective Agents | 2 | 2019 | 155 | 0.630 |
Why?
|
| Diabetic Retinopathy | 4 | 2024 | 165 | 0.600 |
Why?
|
| Vision, Ocular | 1 | 2019 | 128 | 0.550 |
Why?
|
| Trabeculectomy | 2 | 2020 | 17 | 0.550 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2018 | 98 | 0.540 |
Why?
|
| Neuroprotection | 1 | 2018 | 28 | 0.540 |
Why?
|
| Drosophila Proteins | 7 | 2008 | 759 | 0.530 |
Why?
|
| Optic Nerve | 1 | 2018 | 87 | 0.520 |
Why?
|
| Mice, Inbred C57BL | 8 | 2020 | 4521 | 0.520 |
Why?
|
| Action Potentials | 2 | 2019 | 460 | 0.510 |
Why?
|
| Photoreceptor Cells, Invertebrate | 5 | 2008 | 58 | 0.500 |
Why?
|
| Nerve Fibers | 4 | 2024 | 66 | 0.490 |
Why?
|
| Tonometry, Ocular | 5 | 2022 | 30 | 0.490 |
Why?
|
| Nuclear Proteins | 6 | 2008 | 1220 | 0.490 |
Why?
|
| Medical Staff, Hospital | 1 | 2016 | 92 | 0.480 |
Why?
|
| ErbB Receptors | 3 | 2007 | 286 | 0.480 |
Why?
|
| Tomography, Optical Coherence | 6 | 2024 | 499 | 0.480 |
Why?
|
| Immunoglobulin lambda-Chains | 1 | 2015 | 11 | 0.470 |
Why?
|
| Paraproteinemias | 1 | 2015 | 21 | 0.460 |
Why?
|
| Cell Count | 4 | 2016 | 219 | 0.440 |
Why?
|
| Animals | 24 | 2020 | 33235 | 0.430 |
Why?
|
| Filtering Surgery | 1 | 2013 | 4 | 0.410 |
Why?
|
| Eye Diseases | 2 | 2025 | 80 | 0.410 |
Why?
|
| Transcription Factors | 6 | 2008 | 2358 | 0.410 |
Why?
|
| Silver | 1 | 2013 | 28 | 0.410 |
Why?
|
| Mice | 12 | 2020 | 17626 | 0.400 |
Why?
|
| Anti-Infective Agents, Local | 1 | 2013 | 66 | 0.390 |
Why?
|
| Metal Nanoparticles | 1 | 2013 | 54 | 0.390 |
Why?
|
| Drosophila melanogaster | 5 | 2006 | 820 | 0.380 |
Why?
|
| Transcriptome | 1 | 2019 | 1061 | 0.370 |
Why?
|
| Electroretinography | 3 | 2018 | 120 | 0.340 |
Why?
|
| Retinal Diseases | 1 | 2013 | 164 | 0.330 |
Why?
|
| Female | 21 | 2026 | 68045 | 0.290 |
Why?
|
| Night Vision | 2 | 2020 | 6 | 0.280 |
Why?
|
| Eye | 4 | 2006 | 217 | 0.280 |
Why?
|
| Ectropion | 1 | 2007 | 5 | 0.280 |
Why?
|
| Quinazolines | 1 | 2007 | 179 | 0.250 |
Why?
|
| Retinal Detachment | 2 | 2026 | 74 | 0.250 |
Why?
|
| Internship and Residency | 1 | 2016 | 1164 | 0.250 |
Why?
|
| Cell Differentiation | 6 | 2006 | 1850 | 0.240 |
Why?
|
| Homeodomain Proteins | 2 | 2026 | 540 | 0.240 |
Why?
|
| Cell Survival | 2 | 2020 | 836 | 0.240 |
Why?
|
| Microtubule-Associated Proteins | 2 | 2008 | 248 | 0.230 |
Why?
|
| Papilledema | 1 | 2025 | 35 | 0.220 |
Why?
|
| Vision Disorders | 2 | 2017 | 155 | 0.220 |
Why?
|
| Drosophila | 3 | 2008 | 780 | 0.220 |
Why?
|
| Skin | 1 | 2007 | 516 | 0.220 |
Why?
|
| Weightlessness | 1 | 2025 | 42 | 0.220 |
Why?
|
| Pupa | 1 | 2004 | 22 | 0.220 |
Why?
|
| Fluorescent Antibody Technique, Indirect | 2 | 2014 | 99 | 0.210 |
Why?
|
| Cell Cycle Proteins | 3 | 2008 | 679 | 0.210 |
Why?
|
| Axial Length, Eye | 2 | 2014 | 36 | 0.210 |
Why?
|
| Space Flight | 1 | 2025 | 98 | 0.210 |
Why?
|
| Diabetes Mellitus | 2 | 2021 | 876 | 0.200 |
Why?
|
| Male | 15 | 2026 | 62235 | 0.200 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2007 | 572 | 0.200 |
Why?
|
| DNA-Binding Proteins | 3 | 2004 | 1903 | 0.200 |
Why?
|
| Biomarkers | 3 | 2019 | 3150 | 0.190 |
Why?
|
| Ophthalmology | 1 | 2023 | 128 | 0.190 |
Why?
|
| Macula Lutea | 1 | 2022 | 44 | 0.180 |
Why?
|
| Physician's Role | 1 | 2023 | 160 | 0.180 |
Why?
|
| Acceleration | 1 | 2022 | 24 | 0.180 |
Why?
|
| Color | 1 | 2022 | 34 | 0.180 |
Why?
|
| Peripheral Nervous System | 1 | 2002 | 44 | 0.180 |
Why?
|
| Pseudotumor Cerebri | 1 | 2022 | 31 | 0.180 |
Why?
|
| Cell Nucleus | 1 | 2004 | 559 | 0.180 |
Why?
|
| Insect Proteins | 1 | 2001 | 106 | 0.180 |
Why?
|
| Mutation, Missense | 1 | 2026 | 889 | 0.170 |
Why?
|
| Puromycin | 1 | 2020 | 12 | 0.170 |
Why?
|
| Neuronal Outgrowth | 1 | 2020 | 5 | 0.170 |
Why?
|
| Norepinephrine Plasma Membrane Transport Proteins | 1 | 2020 | 7 | 0.170 |
Why?
|
| Corneal Edema | 1 | 2020 | 11 | 0.170 |
Why?
|
| beta-Alanine | 1 | 2020 | 7 | 0.170 |
Why?
|
| Inhibitory Concentration 50 | 1 | 2020 | 85 | 0.170 |
Why?
|
| Humans | 24 | 2026 | 126153 | 0.170 |
Why?
|
| Benzoates | 1 | 2020 | 26 | 0.170 |
Why?
|
| rho-Associated Kinases | 1 | 2020 | 47 | 0.160 |
Why?
|
| Electrophysiology | 1 | 2020 | 250 | 0.160 |
Why?
|
| Photic Stimulation | 1 | 2020 | 214 | 0.160 |
Why?
|
| Epithelium, Corneal | 1 | 2020 | 171 | 0.150 |
Why?
|
| Suppression, Genetic | 2 | 1995 | 42 | 0.140 |
Why?
|
| Gout | 1 | 2021 | 170 | 0.140 |
Why?
|
| Antineoplastic Agents | 1 | 2007 | 1754 | 0.140 |
Why?
|
| Veterans | 2 | 2021 | 1730 | 0.140 |
Why?
|
| Drug-Related Side Effects and Adverse Reactions | 1 | 2020 | 260 | 0.140 |
Why?
|
| Aqueous Humor | 1 | 2017 | 29 | 0.140 |
Why?
|
| Antihypertensive Agents | 2 | 2023 | 389 | 0.140 |
Why?
|
| Microscopy, Electron | 1 | 2018 | 311 | 0.130 |
Why?
|
| Meningeal Carcinomatosis | 1 | 2017 | 2 | 0.130 |
Why?
|
| Repressor Proteins | 1 | 2001 | 765 | 0.130 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2020 | 1598 | 0.130 |
Why?
|
| Cancer Care Facilities | 1 | 2017 | 33 | 0.130 |
Why?
|
| Cell Death | 2 | 2017 | 234 | 0.120 |
Why?
|
| Genes, src | 2 | 1995 | 3 | 0.120 |
Why?
|
| Aged | 10 | 2026 | 20078 | 0.120 |
Why?
|
| Neurodegenerative Diseases | 1 | 2019 | 271 | 0.120 |
Why?
|
| Sequence Analysis, RNA | 1 | 2019 | 417 | 0.120 |
Why?
|
| Middle Aged | 9 | 2026 | 27403 | 0.120 |
Why?
|
| Tertiary Care Centers | 1 | 2017 | 245 | 0.120 |
Why?
|
| Up-Regulation | 1 | 2018 | 829 | 0.120 |
Why?
|
| Thymus Hormones | 1 | 1995 | 2 | 0.120 |
Why?
|
| Photophobia | 1 | 2015 | 8 | 0.110 |
Why?
|
| Tubulin | 1 | 2015 | 68 | 0.110 |
Why?
|
| Retinal Neurons | 1 | 2015 | 13 | 0.110 |
Why?
|
| Cells, Cultured | 1 | 2020 | 2906 | 0.110 |
Why?
|
| Signal Transduction | 2 | 2004 | 4474 | 0.110 |
Why?
|
| Sensory Thresholds | 1 | 2014 | 32 | 0.110 |
Why?
|
| Ribonucleoproteins | 1 | 1995 | 57 | 0.110 |
Why?
|
| Visual Fields | 1 | 2015 | 106 | 0.110 |
Why?
|
| Hospitals, Veterans | 1 | 2016 | 333 | 0.110 |
Why?
|
| Intracranial Pressure | 1 | 2015 | 179 | 0.110 |
Why?
|
| Microscopy, Confocal | 1 | 2015 | 361 | 0.100 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2016 | 1026 | 0.100 |
Why?
|
| United States Department of Veterans Affairs | 1 | 2017 | 687 | 0.100 |
Why?
|
| Blister | 1 | 2013 | 21 | 0.100 |
Why?
|
| Mitomycin | 1 | 2013 | 49 | 0.100 |
Why?
|
| Administration, Topical | 1 | 2013 | 133 | 0.100 |
Why?
|
| Gene Expression Regulation, Developmental | 3 | 2008 | 973 | 0.100 |
Why?
|
| Viral Proteins | 1 | 1995 | 337 | 0.100 |
Why?
|
| Biotin | 1 | 2013 | 40 | 0.100 |
Why?
|
| Antibiotics, Antineoplastic | 1 | 2013 | 124 | 0.100 |
Why?
|
| Rabbits | 1 | 2013 | 640 | 0.100 |
Why?
|
| Axons | 1 | 2015 | 372 | 0.090 |
Why?
|
| Aged, 80 and over | 3 | 2016 | 6582 | 0.090 |
Why?
|
| Drug Therapy, Combination | 1 | 2015 | 1146 | 0.090 |
Why?
|
| Analysis of Variance | 1 | 2013 | 950 | 0.090 |
Why?
|
| Immunohistochemistry | 2 | 2013 | 1604 | 0.090 |
Why?
|
| Transcription, Genetic | 2 | 1995 | 1381 | 0.080 |
Why?
|
| Algorithms | 1 | 2017 | 1639 | 0.080 |
Why?
|
| Electronic Health Records | 1 | 2017 | 770 | 0.080 |
Why?
|
| Eye Neoplasms | 1 | 2010 | 42 | 0.080 |
Why?
|
| Vascular Neoplasms | 1 | 2010 | 31 | 0.080 |
Why?
|
| Lacrimal Apparatus Diseases | 1 | 2010 | 42 | 0.080 |
Why?
|
| Phenotype | 2 | 2018 | 4313 | 0.080 |
Why?
|
| Adult | 7 | 2026 | 30315 | 0.080 |
Why?
|
| Clinical Competence | 1 | 2016 | 983 | 0.080 |
Why?
|
| Disease Progression | 1 | 2015 | 2110 | 0.070 |
Why?
|
| Lymphoma, Large B-Cell, Diffuse | 1 | 2010 | 148 | 0.070 |
Why?
|
| Erlotinib Hydrochloride | 1 | 2007 | 15 | 0.070 |
Why?
|
| Retrospective Studies | 4 | 2023 | 16831 | 0.070 |
Why?
|
| Carcinoma, Small Cell | 1 | 2007 | 39 | 0.070 |
Why?
|
| Streptococcus pyogenes | 2 | 1998 | 80 | 0.070 |
Why?
|
| Case-Control Studies | 2 | 2026 | 3306 | 0.060 |
Why?
|
| Karyopherins | 1 | 2006 | 35 | 0.060 |
Why?
|
| Cicatrix | 1 | 2007 | 121 | 0.060 |
Why?
|
| Streptococcal Infections | 2 | 1998 | 245 | 0.060 |
Why?
|
| Astronauts | 1 | 2025 | 38 | 0.060 |
Why?
|
| Mutation | 5 | 2008 | 5933 | 0.060 |
Why?
|
| Metamorphosis, Biological | 1 | 2004 | 7 | 0.060 |
Why?
|
| Cross-Sectional Studies | 2 | 2024 | 3658 | 0.050 |
Why?
|
| Whole Genome Sequencing | 1 | 2026 | 323 | 0.050 |
Why?
|
| Microscopy, Electron, Scanning | 1 | 2004 | 126 | 0.050 |
Why?
|
| Bimatoprost | 1 | 2023 | 2 | 0.050 |
Why?
|
| Cloprostenol | 1 | 2023 | 4 | 0.050 |
Why?
|
| Heterozygote | 1 | 2026 | 691 | 0.050 |
Why?
|
| Protein Tyrosine Phosphatases | 1 | 2003 | 76 | 0.050 |
Why?
|
| Ophthalmic Solutions | 1 | 2023 | 89 | 0.050 |
Why?
|
| Amides | 1 | 2023 | 89 | 0.050 |
Why?
|
| Cell Lineage | 1 | 2004 | 325 | 0.050 |
Why?
|
| Molecular Sequence Data | 4 | 2008 | 3604 | 0.050 |
Why?
|
| Cerebrospinal Fluid Pressure | 1 | 2022 | 14 | 0.050 |
Why?
|
| Eye Proteins | 1 | 2003 | 231 | 0.050 |
Why?
|
| Syndrome | 1 | 2025 | 1114 | 0.050 |
Why?
|
| Neuroglia | 1 | 2004 | 211 | 0.050 |
Why?
|
| Animals, Genetically Modified | 3 | 2008 | 327 | 0.040 |
Why?
|
| Biological Specimen Banks | 1 | 2021 | 56 | 0.040 |
Why?
|
| United Kingdom | 1 | 2021 | 235 | 0.040 |
Why?
|
| Slit Lamp Microscopy | 1 | 2020 | 4 | 0.040 |
Why?
|
| Glaucoma Drainage Implants | 1 | 2020 | 9 | 0.040 |
Why?
|
| Descemet Stripping Endothelial Keratoplasty | 1 | 2020 | 10 | 0.040 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2004 | 588 | 0.040 |
Why?
|
| Base Sequence | 3 | 2008 | 2773 | 0.040 |
Why?
|
| Genetic Testing | 1 | 2006 | 1059 | 0.040 |
Why?
|
| Corneal Diseases | 1 | 2020 | 94 | 0.040 |
Why?
|
| Cataract Extraction | 1 | 2020 | 145 | 0.040 |
Why?
|
| Lens Implantation, Intraocular | 1 | 2020 | 215 | 0.040 |
Why?
|
| Genome-Wide Association Study | 1 | 2026 | 1730 | 0.040 |
Why?
|
| Prospective Studies | 2 | 2021 | 6178 | 0.040 |
Why?
|
| Self Report | 1 | 2021 | 533 | 0.040 |
Why?
|
| 3T3 Cells | 2 | 1995 | 121 | 0.040 |
Why?
|
| Nerve Tissue Proteins | 1 | 2004 | 1097 | 0.030 |
Why?
|
| Lung Neoplasms | 1 | 2007 | 1499 | 0.030 |
Why?
|
| DNA, Complementary | 2 | 1995 | 435 | 0.030 |
Why?
|
| Visual Acuity | 1 | 2020 | 644 | 0.030 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2026 | 2750 | 0.030 |
Why?
|
| Carrier State | 1 | 1997 | 76 | 0.030 |
Why?
|
| Enhancer Elements, Genetic | 2 | 2008 | 271 | 0.030 |
Why?
|
| ROC Curve | 1 | 2017 | 566 | 0.030 |
Why?
|
| Genes, Regulator | 1 | 1995 | 43 | 0.030 |
Why?
|
| Heterogeneous-Nuclear Ribonucleoprotein Group A-B | 1 | 1995 | 11 | 0.030 |
Why?
|
| Cations | 1 | 2015 | 37 | 0.030 |
Why?
|
| Electron Transport Complex IV | 1 | 1995 | 40 | 0.030 |
Why?
|
| Sequence Homology | 1 | 1995 | 60 | 0.030 |
Why?
|
| Heterogeneous Nuclear Ribonucleoprotein A1 | 1 | 1995 | 9 | 0.030 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2026 | 3258 | 0.030 |
Why?
|
| A Kinase Anchor Proteins | 1 | 1995 | 21 | 0.030 |
Why?
|
| Retinal Bipolar Cells | 1 | 2015 | 39 | 0.030 |
Why?
|
| Chloride Channels | 1 | 2015 | 60 | 0.030 |
Why?
|
| Cysteine Endopeptidases | 1 | 1995 | 106 | 0.030 |
Why?
|
| Mitosis | 1 | 1995 | 191 | 0.030 |
Why?
|
| Nucleic Acid Hybridization | 1 | 1995 | 297 | 0.030 |
Why?
|
| Genes, Tumor Suppressor | 1 | 1995 | 200 | 0.030 |
Why?
|
| Neurons | 1 | 2004 | 1923 | 0.030 |
Why?
|
| DNA Helicases | 1 | 1995 | 229 | 0.030 |
Why?
|
| Severity of Illness Index | 1 | 2021 | 2927 | 0.030 |
Why?
|
| Collagen | 1 | 1995 | 296 | 0.030 |
Why?
|
| Databases, Factual | 1 | 2017 | 1171 | 0.020 |
Why?
|
| Diagnosis, Differential | 1 | 2017 | 1823 | 0.020 |
Why?
|
| Polymerase Chain Reaction | 1 | 1995 | 1490 | 0.020 |
Why?
|
| Synapses | 1 | 2015 | 433 | 0.020 |
Why?
|
| Antigens, CD20 | 1 | 2010 | 39 | 0.020 |
Why?
|
| Reproducibility of Results | 1 | 2017 | 2878 | 0.020 |
Why?
|
| Ki-67 Antigen | 1 | 2010 | 102 | 0.020 |
Why?
|
| Retinal Hemorrhage | 1 | 2010 | 22 | 0.020 |
Why?
|
| Paraplegia | 1 | 2010 | 75 | 0.020 |
Why?
|
| Models, Biological | 1 | 2015 | 1375 | 0.020 |
Why?
|
| Risk Factors | 2 | 2021 | 10376 | 0.020 |
Why?
|
| Proteins | 1 | 1995 | 1020 | 0.020 |
Why?
|
| Lacrimal Apparatus | 1 | 2010 | 127 | 0.020 |
Why?
|
| Sequence Analysis, DNA | 1 | 1995 | 1739 | 0.020 |
Why?
|
| DNA Probes | 1 | 2008 | 118 | 0.020 |
Why?
|
| Genes, Insect | 1 | 2008 | 121 | 0.020 |
Why?
|
| Body Patterning | 1 | 2008 | 129 | 0.020 |
Why?
|
| Electrophoresis, Gel, Pulsed-Field | 2 | 1998 | 92 | 0.020 |
Why?
|
| Models, Neurological | 1 | 2008 | 185 | 0.020 |
Why?
|
| Serotyping | 2 | 1998 | 172 | 0.020 |
Why?
|
| Minnesota | 2 | 1998 | 172 | 0.020 |
Why?
|
| Biopsy | 1 | 2010 | 1221 | 0.020 |
Why?
|
| Cilia | 1 | 2006 | 76 | 0.020 |
Why?
|
| Amino Acid Sequence | 2 | 2003 | 2555 | 0.010 |
Why?
|
| Rhodopsin | 1 | 2004 | 66 | 0.010 |
Why?
|
| Larva | 1 | 2004 | 252 | 0.010 |
Why?
|
| Substrate Specificity | 1 | 2003 | 283 | 0.010 |
Why?
|
| Biomarkers, Tumor | 1 | 2010 | 1574 | 0.010 |
Why?
|
| United States | 1 | 2017 | 11191 | 0.010 |
Why?
|
| Phosphorylation | 1 | 2003 | 1540 | 0.010 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2010 | 3593 | 0.010 |
Why?
|
| Fasciitis, Necrotizing | 1 | 1998 | 26 | 0.010 |
Why?
|
| Pharyngitis | 1 | 1997 | 34 | 0.010 |
Why?
|
| Molecular Epidemiology | 1 | 1997 | 144 | 0.010 |
Why?
|
| Virulence | 1 | 1997 | 269 | 0.010 |
Why?
|
| Genes, Bacterial | 1 | 1997 | 217 | 0.010 |
Why?
|
| Cluster Analysis | 1 | 1997 | 410 | 0.010 |
Why?
|
| Transformation, Genetic | 1 | 1995 | 29 | 0.010 |
Why?
|
| DNA, Bacterial | 1 | 1997 | 484 | 0.010 |
Why?
|
| Genes, ras | 1 | 1995 | 100 | 0.010 |
Why?
|
| Disease Outbreaks | 1 | 1997 | 307 | 0.010 |
Why?
|
| Schools | 1 | 1997 | 233 | 0.010 |
Why?
|
| Protein Biosynthesis | 1 | 1995 | 565 | 0.010 |
Why?
|
| Rats | 1 | 1995 | 3394 | 0.000 |
Why?
|
| Child | 1 | 1997 | 25112 | 0.000 |
Why?
|